butylscopolammonium bromide has been researched along with oxyphenbutazone in 2 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (oxyphenbutazone) | Trials (oxyphenbutazone) | Recent Studies (post-2010) (oxyphenbutazone) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 1,237 | 148 | 24 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | oxyphenbutazone (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 12.5 | |
| caspase recruitment domain family, member 15 | Homo sapiens (human) | 6.633 | |
| receptor-interacting serine/threonine-protein kinase 2 isoform 1 | Homo sapiens (human) | 6.633 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Belhaj, MS; Bharija, SC; Kanwar, AJ; Mohammed, M | 1 |
2 other study(ies) available for butylscopolammonium bromide and oxyphenbutazone
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Drugs causing fixed eruptions.
Topics: Adult; Aspirin; Butylscopolammonium Bromide; Cross Reactions; Dipyrone; Drug Eruptions; Drug Interactions; Female; Humans; Ibuprofen; Male; Oxyphenbutazone; Sulfadiazine; Tetracycline | 1984 |